MBT SEPSIMATIC

What this means for you

Not registered yet, but its 25 Mar 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

79423159

Mark type

Stylized text

Filed

25 Mar 2025

Attorney of record

Paul Novak

Goods and services

• Class 001 — Chemicals: Reagents for scientific purposes; Media for cell culture for use in non-medical research laboratories; Buffer solutions for scientific purposes, in particular lysis buffer media and washing buffer media; Media for microbiological culture or cell culture for use in separation techniques, not for medical use, in particular extraction media; Reagents for analytical purposes, not for medical or veterinary purposes, in particular matrix substance media; Chemical-biological test kits for detecting sepsis for scientific purposes comprising buffer solutions, reagents, media and matrix substance media; Reagents for scientific purposes, media for microbiological culture or cell culture for use in separation techniques for use in non-medical research laboratories, buffer solutions for scientific purposes, in particular lysis buffer media and washing buffer media, media for use in separation techniques, not for medical use, in particular extraction media, reagents for analytical purposes, other than for medical or veterinary purposes, in particular matrix substance media, and chemical- biological test kits comprising buffer solutions, reagents, media and matrix substance media, all for detecting sepsis for research use for non-medical, nonclinical and non-veterinary diagnostics; Reagents for scientific purposes, media for microbiological culture or cell culture for use in separation techniques for use in non-medical research laboratories, buffer solutions for scientific purposes, in particular lysis buffer media and washing buffer media, media for use in separation techniques, not for medical use, in particular extraction media, reagents for analytical purposes, other than for medical or veterinary purposes, in particular matrix substance media, and chemical-biological test kits comprising buffer solutions, reagents, media and matrix substance media, all for detecting sepsis for research use, that separate and process microbial and non-microbial cells, including bacteria, yeasts, fungi, particles including virions, and parts of these cells and particles, from a liquid culture
• Class 005 — Pharmaceuticals: Reagents and media for medical and veterinary diagnostic purposes, in particular culture media, extraction media and diagnostic media; Reagents and media for medical and veterinary diagnostic purposes, in particular culture media, extraction media and diagnostic media, for use with detecting sepsis; Diagnostic test kits comprised of medical diagnostic reagents and assays for testing blood or blood culture samples for use in detecting sepsis, for medical, clinical and veterinary diagnostics; Reagents and media for medical and veterinary diagnostic purposes, in particular culture media, extraction media and diagnostics media, for use with detecting sepsis, and diagnostic test kits comprised of medical diagnostic reagents and assays for testing blood or blood culture samples for use in detecting sepsis, that separate and process microbial and non-microbial cells, including bacteria, yeasts, fungi, particles including virions, and part of these cells and particles, from a liquid culture, including a body fluid culture, in particular a blood culture
• Class 009 — Scientific and electric apparatus: Laboratory apparatus and instruments other than for medical use, namely, automated sample processing stations, robotic arms, and fluid handling systems for scientific analysis; Laboratory apparatus and instruments, namely apparatus and equipment for taking, processing and/or preparation of biological samples from a vessel for analytical purposes, in particular a fully or partially automated blood culture sampling and processing station for taking blood culture samples from blood culture bottles and processing and preparing the samples for further mass spectrometric analysis with the purpose of identification of microorganism in the samples and/or a sepsis; Embedded computer programs and computer software for controlling laboratory instruments other than for medical use, namely, automated sample processing stations, robotic arms, and fluid handling systems for scientific analysis; Embedded computer programs and computer software for controlling an apparatus for taking, preparation and processing of samples from a vessel for scientific purposes, in particular blood culture samples, for the analysis by mass spectrometry and for analyzing mass spectra data, and/or for identifying microorganisms including bacteria, yeasts and fungi, and particles including virions in a liquid culture from biological, industrial and food samples

Owner

• Bruker Daltonics GmbH & Co. KG, DE

Prosecution history

• 23 Dec 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
• 23 Dec 2025 — FINAL REFUSAL E-MAILED
• 23 Dec 2025 — FINAL REFUSAL WRITTEN
• 21 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 20 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 20 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 16 Aug 2025 — REFUSAL PROCESSED BY IB
• 28 Jul 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
• 28 Jul 2025 — REFUSAL PROCESSED BY MPU
• 05 Jun 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
• 04 Jun 2025 — NON-FINAL ACTION WRITTEN
• 04 Jun 2025 — ASSIGNED TO EXAMINER
• 10 May 2025 — APPLICATION FILING RECEIPT MAILED
• 10 May 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 08 May 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB